KUMON HIROMI has a total of 19 patent applications. Its first patent ever was published in 2000. It filed its patents most often in United States, Japan and China. Its main competitors in its focus markets pharmaceuticals and biotechnology are ZOETIS BELGIUM S A, TAPIMMUNE INC and GENE SIGNAL INT SA.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | Japan | 4 | |
#3 | China | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Microorganisms | |
#5 | Fermentation |
# | Name | Total Patents |
---|---|---|
#1 | Kumon Hiromi | 16 |
#2 | Sakaguchi Masakiyo | 12 |
#3 | Nasu Yasutomo | 12 |
#4 | Huh Nam-Ho | 11 |
#5 | Watanabe Masami | 6 |
#6 | Abarzua Cabezas Fernando Guillermo | 5 |
#7 | Tsuji Toshiya | 3 |
#8 | Kashiwakura Yuji | 3 |
#9 | Nanba Masayoshi | 2 |
#10 | Huh Namho | 1 |
Publication | Filing date | Title |
---|---|---|
US2012309050A1 | System for increasing gene expression and vector comprising the system | |
US2011189237A1 | Therapeutic agent for malignant mesothelioma and immunostimulant | |
US2010173404A1 | Partial fragment of REIC/Dkk-3 gene and cancer therapeutic agent comprising the same | |
WO2006098074A1 | Apoptosis inducing agent for prostate carcinoma cell | |
JP2005334578A | Noninvasive system for diagnosing urination disorder by intelligence robot | |
EP1234877A1 | Cell proliferation inhibitory protein, polynucleotide, antisense polynucleotide to the polynucleotide, and cell proliferation inhibitors, cancer diagnostics, cancer remedies and compositions for gene therapy by using the same |